Deuterium Metabolic Imaging in People with Multiple Sclerosis
Recruiting
Observational Study
Multiple Sclerosis (MS) - Relapsing-remitting
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- University of Aarhus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this case-control study is to investigate glucose brain metabolism in people with multiple sclerosis and age- and sex-matched healthy controls. The main questions it aims to answer are:
* How does brain glucose metabolism in people with multiple sclerosis compare to age- and sex-matched healthy controls?
* How is the brain glucose metabolism of people with multiple sclerosis associate…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged 18-60 years.
* Definite Relapsing remitting multiple sclerosis diagnosis according to the most recent diagnostic criteria
Exclusion Criteria:
* Contraindications for MRI:
Pacemaker, neurostimulator or cholera implant. Metal foreign bodies such as fragments and irremova…
Contacts